IMMUNOTHERAPY WITH LOW-DOSE RECOMBINANT INTERLEUKIN-2 AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEUROBLASTOMA.